ISSN: 2329-6631
Journal of Developing Drugs
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business
 

The Very Dangerous Risk of Using Pills for Weight Loss and Contraceptive Pills in Same Time

Manuela Stoicescu*
*Corresponding Author : Manuela Stoicescu
Consultant Internal Medicine
Assistant Professor, University of Oradea
Faculty of Medicine and Pharmacy
Medical Disciplines Department, Romania
Tel: 072-301-9951
E-mail:manuela_stoicescu@yahoo.com
Received November 29, 2013; Accepted April 02, 2014; Published April 07, 2014
Citation: JStoicescu M (2014) The Very Dangerous Risk of Using Pills for Weight Loss and Contraceptive Pills in Same Time. J Develop Drugs 3:118. doi:10.4172/2329-6631.1000118
Copyright: © 2014 Stoicescu M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Developing Drugs

Abstract

The main objective of this clinical case report was to specify that the administration of pills for weight loss and contraceptive pills in same time could develop unexpected, very dangerous side effects like sudden death in a few minutes if we are not careful and we do not continuously informed our patients.

Objectives
The main objective of this clinical case report was to specify that the administration of pills for weight loss and contraceptive pills in same time could develop unexpected, very dangerous side effects like sudden death in a few minutes if we are not careful and we do not continuously informed our patients.
Materials and Methods
I present the clinical case of a women patient 39 year’s old, obese, smoker, who presented at home sudden constrictive chest pain, severe dyspnea (difficulty in breathing) and came with the Ambulance in the Emergency Department with cardio respiratory stop. After performed the standard protocol for resuscitation with adrenaline i.v. and electric shock repeated three times she revue in sinus rhythm and continue i.v. perfusion with xilina to maintain the sinus rhythm. The objective examination revealed very severe cyanosis of the lips (Figure 1), tongue (Figure 2) years, nails of the hands (Figures 3a and 3b) and legs.
The laboratory test showed: normal range Troponin T=0.1 μg/L, CPK MB= 2 ng/ml, TGO=28UI/l, TGP=31UI/l and increase level of D Dimmer=350 ng/mL
The EKG in the first instance was iso electric line (Figure 4) because she was in cardio respirator stop but after resuscitation the EKG looked in normal sinus rhythm (Figure 5) without any changes.
The normal level of the cardiac enzymes and normal EKG after resuscitation excluded a possible acute myocardial infarction but the increase level of D dimmer suspect the possibility of pulmonary embolism. The echocardiography of the heart in Emergency was
normal and excluded also a possible acute dissection of the aorta. Also she performed an eco-Doppler of the vein but was normal and excluded the diagnosis of deep vein thrombosis.
In this moment the principal suspicion of diagnosis was pulmonary embolism but without possibility to know the source for embolism. A thoracic CT angiogram (Figure 6) was performed and confirmed this diagnosis.
This image shows an intraluminal filling defect that occludes the anterior basal segmental artery of the right lower lobe. Also present is an infarction of the corresponding lung, which is indicated by a triangular, pleura-based consolidation (Hampton hump).
Diagnosis
Stop cardio respirator. Pulmonary embolism
Therapy
After this confirmation the patient started immediately administration of Heparin i.v. continue with injectomat 1000UI/h with monitories of the PTT.
Evolution
After approximate 30 minutes again develop cardio respirator stop with iso electric line on monitor and was performed the standard protocol for resuscitation with adrenaline i.v. and electric soc repeated but this time after 40min of resuscitation the patient didn’t revue in sinus rhythm and the protocol was declared inefficient and the patient died. Autopsy relieved massive pulmonary embolism in the right principal pulmonary artery.
Final Diagnosis
Stop cardio respirator, sudden death, pulmonary embolism in the right principal pulmonary artery.
Results and Discussions
The most important problem of this clinical case presentation was what produces the pulmonary embolism? The patient didn’t present deep vein thrombosis. An eco-Doppler venous was performed in the Emergency Department and was normal. Of course exist pulmonary embolism in situ but a cause must to be discovered.
After this unhappy event a discussion with the husband of the patient relived unexpected that she used for many four years every days pills for weight loss and contraceptive pills without pause in context if this patient was obese and also smoker 10 cigarettes /days last 8 year.
The combination of contraceptive pills and pills for weight loss in this clinical context with cardiovascular risks factor obesity and smoker develop very severe and massive pulmonary embolism with sudden death in context of correct protocol of treatment.
The risk of contraceptive pills to develop pulmonary embolism it is very well known. The combination between pills for weight loss and contraceptive pills it is insufficiently studied. In context of this patient with other cardiovascular risks factors present such as obesity and smoking it is very possible to contribute at the acute pulmonary embolism.
Most weight loss medications are only recommended for short period of time to use (up to 12 weeks). This patient used a very long period of time four years this medications without pause and also in combinations with dangerous contraceptive pills also without pause (continues). Dependence, abuse or withdrawal may occur with longterm use. Pills for weight loss develop usually side effects may include: increased blood pressure and heart rate, insomnia, nervousness, blurred vision, restlessness, or headache.
Chest pain, difficult in breath wasn’t reported yet but in context of other cardiovascular risks factors such as smoking and of course obesity, sedentary and also in combination with contraceptive pills could appear. These pills may have side effects, especially when not used correctly. The side effects produced by this weight loss pills can be avoided. Serious side effects caused primary pulmonary hypertension in some users, which can lead to respiratory failure and death. Birth control pills increase the risk of blood clots (thromboembolism). Of course are other options for birth control that are far less dangerous.
Consider that these combinations between these two types of pills, incorrect used, long period of time without pause, by women with lack information’s, together with other cardiovascular risks factors become dangerous. We must to give importance in our medical practice at this new phenomenon.
Conclusion
I think that this clinical case didn’t must to be cover in our medical practice and it is important to be presented because the women must to know the potential very dangerous risk of this combinations of pills and to avoid another similar unhappy events in the future.
Select your language of interest to view the total content in your interested language
 
Share This Article
   
 
   
 
Relevant Topics
Disc Adverse Drug Reactions
Disc Antigen – Antibody Reaction
Disc Anvisa Drug Safety Regulations
Disc Biochemical Metabolism
Disc Clinical Pharmacoepidemiological Trails
Disc Cytochrome 450 Drug Metabolism
Disc Cytotoxicity
Disc Detoxification
Disc Drug Delivery
Disc Drug Delivery Systems
Disc Drug Delivery using Nanotechnology
Disc Drug Designing
Disc Drug Development
Disc Drug Discovery
Disc Drug Interaction
Disc Drug Interactions
Disc Drug Metabolism
Disc Drug Safety Databases
Disc Drug Safety Information Maintenance
Disc Drug Safety Regulations
Disc Drug Therapy
Disc Drug Toxicology
Disc Drug drug interaction
Disc Drug food interaction
Disc Drugs metabolised by CYP2D6
Disc Europeon Drug Safety Regulations
Disc Expert Opinions on Drug Safety
Disc Fragment Based Drug Design
Disc Germ cell tumours
Disc Heat Shock Proteins
Disc Hepatic Metabolism of Drugs
Disc In Silico Methods
Disc Liver Drug Metabolism
Disc Medication Errors
Disc Molecular Modeling
Disc Nanomedicals
Disc Peptidomimetic
Disc Pharmaceutical Industry
Disc Pharmaceutical Toxicology
Disc Pharmacoepidemiological Studies
Disc Pharmacotherapy
Disc Phase I Drug Metabolism
Disc Phase II Drug Metabolism
Disc Pre-Clinical Drug Development
Disc Protease Substrate/Inhibitor
Disc Receptor Agonist/ Antagonist
Disc Reviews on Drug Safety
Disc Structure Based Drug Design
Disc UK Drug Safety Regulations
Disc US Drug Safety Regulations
Disc screening and Drug Design
 
Recommended Journals
Disc Pharmaceutical Sciences & Emerging Drugs Journal
Disc Pharmaceutics & Drug Delivery Research Journal
Disc Drug Metabolism & Toxicology Journal
Disc Drug Development & Research International Journal
Disc Drug Designing: Open Access
Disc Drug Designing: Open Access
Disc Advances in Pharmacoepidemiology & Drug Safety
  View More»
 
Recommended Conferences
Disc Asia-Pacific Drug Formulation
July 11-13, 2016 Kuala Lumpur, Malaysia
Disc Conference on Nanomedicine
July 25-27, 2016 Bangkok, Thailand
Disc Conference on GMP GCP Quality Control
August 15-16, 2016 Toronto, Ontario, Canada
Disc Global Pharma Conference
August 22-24, 2016 New Orleans, Louisiana, USA
Disc Generic Drug Market
October 31 – November 2, 2016 Valencia, Spain
Disc Conference on Parenterals
November 07-08, 2016 Istanbul, Turkey
Disc Conference on Pharma Marketing
Nov 10-12, 2016 Alicante, Spain
Disc Polymer Chemistry Conference
November 14-16, 2016 Atlanta, USA
 
Article Tools
Disc Export citation
Disc Share/Blog this article
 
Article usage
  Total views: 11136
  [From(publication date):
August-2014 - Jul 01, 2016]
  Breakdown by view type
  HTML page views : 7408
  PDF downloads :3728
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Materials Science Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version